Cabozantinib for previously treated radioiodine‐refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC‐311 trial

Author:

Brose Marcia S.12,Robinson Bruce G.3,Sherman Steven I.4,Jarzab Barbara5,Lin Chia‐Chi6,Vaisman Fernanda7,Hoff Ana O.8,Hitre Erika9,Bowles Daniel W.10,Sen Suvajit11,Oliver Jennifer W.11,Banerjee Kamalika11,Keam Bhumsuk12ORCID,Capdevila Jaume13

Affiliation:

1. Abramson Cancer Center University of Pennsylvania Philadelphia Pennsylvania USA

2. Now at Sidney Kimmel Cancer Center, Jefferson Health Philadelphia PA USA

3. Sydney Medical School University of Sydney Sydney New South Wales Australia

4. Department of Endocrine Neoplasia and Hormonal Disorders The University of Texas MD Anderson Cancer Center Houston Texas USA

5. Department of Nuclear Medicine and Endocrine Oncology Maria Sklodowska Curie National Research Institute of Oncology Gliwice Poland

6. Department of Oncology National Taiwan University Hospital Taipei Taiwan

7. Endocrinology Service Instituto Nacional de Câncer Rio de Janeiro Brazil

8. Department of Endocrinology Instituto do Câncer do Estado de São Paulo Universidade de São Paulo São Paulo Brazil

9. Department of Medical Oncology and Clinical Pharmacology “B” Országos Onkológiai Intézet Budapest Hungary

10. Division of Medical Oncology Department of Medicine Anschutz Medical Campus, University of Colorado Aurora Colorado USA

11. Exelixis, Inc. Alameda California USA

12. Department of Internal Medicine Seoul National University Hospital Seoul Republic of Korea

13. Medical Oncology Department Gastrointestinal and Endocrine Tumor Unit Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO) Universitat Autònoma de Barcelona Barcelona Spain

Publisher

Wiley

Subject

Cancer Research,Oncology

Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3